We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Practical advice and tools to support health and care professionals make brief interventions in weight management for adults.
Resources to support the commissioning and delivery of tier 2 behavioural weight management services for children, families and adults.
These documents explain how OHID is approaching reduction and food and drink reformulation as part of the government’s obesity strategy.
Anyone who suspects that they’ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA.
This article presents findings from a systematic review and meta-analysis
Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.
Practical advice and tools to support health and care professionals have conversations about weight management with children and their families.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).